Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes of adding vincristine to procarbazine-lomustine in patients with gliomas: insights from current evidence.

Ecancermedicalscience·2026
Same author

Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Radiosensitization of Glioblastoma by the K-ras Inhibitor RMC-6236.

bioRxiv : the preprint server for biology·2026
Same author

Modern molecular profiling recontextualizes the NRG/RTOG 0539 trial and reveals hidden high-risk and radiotherapy-resistant meningiomas.

Neuro-oncology·2026
Same author

Clinical Outcomes and Patterns of Neurological Toxicity After Stereotactic Body Radiotherapy Reirradiation (reSBRT) of Spine Metastases Previously Treated with SBRT.

Cancers·2026
Same author

Radiation treatment patterns for breast cancer brain metastases: an NCDB analysis.

Breast cancer research and treatment·2026

Related Experiment Video

Updated: Jun 1, 2025

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.5K

FLASH Radiotherapy: From In Vivo Data to Clinical Translation.

Heather R Manring1, Jessica L Fleming1, Wei Meng1

  • 1Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Hematology/Oncology Clinics of North America
|January 19, 2025
PubMed
Summary
This summary is machine-generated.

FLASH radiotherapy (FLASH-RT) shows promise for cancer treatment, potentially improving survival and quality of life. Further research is needed to explore its combination with other therapies and confirm its clinical utility.

Keywords:
Clinical translation and therapeutic ratioFLASH effectFLASH radiotherapyNormal tissue sparingUltra-high dose rate

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K
Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

11.9K

Related Experiment Videos

Last Updated: Jun 1, 2025

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.5K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K
Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

11.9K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Radiotherapy (RT) is a cornerstone of cancer treatment.
  • Emerging ultra-high dose rate delivery, known as FLASH radiotherapy (FLASH-RT), presents a novel approach.
  • Preclinical data suggest potential benefits for both normal tissues and tumors.

Purpose of the Study:

  • To review the current evidence for FLASH-RT.
  • To highlight the potential benefits and challenges of FLASH-RT.
  • To discuss future research directions for FLASH-RT.

Main Methods:

  • Review of in vivo data from various normal tissues and tumors.
  • Analysis of potential combinations with other cancer treatments.
  • Evaluation of early-phase clinical trial results.

Main Results:

  • FLASH-RT demonstrates a "FLASH effect" in numerous preclinical studies.
  • Potential synergistic effects with spatially fractionated RT, immunotherapy, and reirradiation are suggested.
  • Phase I clinical trials have yielded promising initial outcomes.

Conclusions:

  • FLASH-RT is a promising emerging cancer treatment with potential to improve patient outcomes.
  • Further research is essential to optimize its application and validate its efficacy.
  • Additional studies are warranted before widespread clinical adoption of FLASH-RT.